These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Exploration of the classification of polycystic ovarian syndrome]. Lin JF; Li X; Zhu MW Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924 [TBL] [Abstract][Full Text] [Related]
23. Impact of adrenal versus ovarian androgen ratio on signs and symptoms of polycystic ovarian syndrome. Köşüş N; Köşüş A; Kamalak Z; Hızlı D; Turhan NÖ Gynecol Endocrinol; 2012 Aug; 28(8):611-4. PubMed ID: 22296561 [TBL] [Abstract][Full Text] [Related]
24. Morning plasma cortisol is low among obese women with polycystic ovary syndrome. Shabir I; Ganie MA; Praveen EP; Khurana ML; John J; Gupta N; Kumar G; Ammini AC Gynecol Endocrinol; 2013 Dec; 29(12):1045-7. PubMed ID: 23957781 [TBL] [Abstract][Full Text] [Related]
25. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879 [TBL] [Abstract][Full Text] [Related]
26. Android fat distribution affects some hemostatic parameters in women with polycystic ovary syndrome compared with healthy control subjects matched for age and body mass index. de Mendonça-Louzeiro MR; Annichino-Bizzacchi JM; Benetti-Pinto CL Fertil Steril; 2015 Aug; 104(2):467-73. PubMed ID: 26051101 [TBL] [Abstract][Full Text] [Related]
27. Prevalence of polycystic ovary syndrome in girls aged 14-18 years in Isfahan, Iran. Hashemipour M; Faghihimani S; Zolfaghary B; Hovsepian S; Ahmadi F; Haghighi S Horm Res; 2004; 62(6):278-82. PubMed ID: 15523185 [TBL] [Abstract][Full Text] [Related]
28. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome. Kazerooni T; Dehghan-Kooshkghazi M Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019 [TBL] [Abstract][Full Text] [Related]
29. Sexual and relational satisfaction in couples where the woman has polycystic ovary syndrome: a dyadic analysis. De Frène V; Verhofstadt L; Loeys T; Stuyver I; Buysse A; De Sutter P Hum Reprod; 2015 Mar; 30(3):625-31. PubMed ID: 25534460 [TBL] [Abstract][Full Text] [Related]
30. Body size from birth to adulthood as a predictor of self-reported polycystic ovary syndrome symptoms. Laitinen J; Taponen S; Martikainen H; Pouta A; Millwood I; Hartikainen AL; Ruokonen A; Sovio U; McCarthy MI; Franks S; Järvelin MR Int J Obes Relat Metab Disord; 2003 Jun; 27(6):710-5. PubMed ID: 12833115 [TBL] [Abstract][Full Text] [Related]
31. Plasma visfatin level in women with polycystic ovary syndrome. Dıkmen E; Tarkun I; Cantürk Z; Cetınarslan B Gynecol Endocrinol; 2011 Jul; 27(7):475-9. PubMed ID: 20586547 [TBL] [Abstract][Full Text] [Related]
32. Ovarian morphology and prevalence of polycystic ovary syndrome in reproductive aged women with or without mild acne. Kelekci KH; Kelekci S; Incki K; Ozdemir O; Yilmaz B Int J Dermatol; 2010 Jul; 49(7):775-9. PubMed ID: 20618496 [TBL] [Abstract][Full Text] [Related]
33. Association of sympathovagal imbalance with cardiovascular risks in patients with polycystic ovary syndrome. Kuppusamy S; Pal GK; Habeebullah S; Ananthanarayanan PH; Pal P Endocr Res; 2015; 40(1):37-43. PubMed ID: 24866562 [TBL] [Abstract][Full Text] [Related]
34. Interleukin-6 levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome. Küçük M; Altınkaya SÖ; Nergiz S; Sezer SD; Yüksel H; Bağlı İ; Yıldız G Gynecol Endocrinol; 2014 Jun; 30(6):423-7. PubMed ID: 24628003 [TBL] [Abstract][Full Text] [Related]
35. Nitric oxide and fibrinogen in polycystic ovary syndrome: associations with insulin resistance and obesity. Nácul AP; Andrade CD; Schwarz P; de Bittencourt PI; Spritzer PM Eur J Obstet Gynecol Reprod Biol; 2007 Aug; 133(2):191-6. PubMed ID: 17049715 [TBL] [Abstract][Full Text] [Related]
36. Sexual function in women with polycystic ovary syndrome. Stovall DW; Scriver JL; Clayton AH; Williams CD; Pastore LM J Sex Med; 2012 Jan; 9(1):224-30. PubMed ID: 22082203 [TBL] [Abstract][Full Text] [Related]
37. Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome. Harborne L; Fleming R; Lyall H; Sattar N; Norman J J Clin Endocrinol Metab; 2003 Sep; 88(9):4116-23. PubMed ID: 12970273 [TBL] [Abstract][Full Text] [Related]
38. Hormonal profile in women with polycystic ovarian syndrome with or without type 1 diabetes mellitus. Codner E; Iñíguez G; Villarroel C; Lopez P; Soto N; Sir-Petermann T; Cassorla F; Rey RA J Clin Endocrinol Metab; 2007 Dec; 92(12):4742-6. PubMed ID: 17895317 [TBL] [Abstract][Full Text] [Related]
39. Self-Reported Polycystic Ovary Syndrome Is Associated With Hypertension: A Northern Finland Birth Cohort 1966 Study. Ollila ME; Kaikkonen K; Järvelin MR; Huikuri HV; Tapanainen JS; Franks S; Piltonen TT; Morin-Papunen L J Clin Endocrinol Metab; 2019 Apr; 104(4):1221-1231. PubMed ID: 30445634 [TBL] [Abstract][Full Text] [Related]
40. Clinical and biochemical presentation of polycystic ovary syndrome in women between the ages of 20 and 40. Liang SJ; Hsu CS; Tzeng CR; Chen CH; Hsu MI Hum Reprod; 2011 Dec; 26(12):3443-9. PubMed ID: 21926412 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]